Kiora Pharmaceuticals
KPRX
KPRX
17 hedge funds and large institutions have $425K invested in Kiora Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Holders
17
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$201K | |
| 2 | +$162K | |
| 3 | +$12.9K | |
| 4 |
HF
HRT Financial
New York
|
+$8K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$7.93K |
Top Sellers
| 1 | -$47.2K | |
| 2 | -$40.9K | |
| 3 | -$40.4K | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$1.03K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$85 |